Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
CrossAmerica Partners LP Unit | CAPL | Dec 24, 2024 | 21.60 | +0.09 |
CrossFirst Bankshares | CFB | Dec 24, 2024 | 15.66 | -0.19 |
CrowdStrike A | CRWD | Dec 24, 2024 | 365.79 | +1.19 |
Crown Castle | CCI | Dec 24, 2024 | 91.00 | +0.28 |
Crown Crafts | CRWS | Dec 24, 2024 | 4.53 | +1.12 |
Crown ElectroKinetics | CRKN | Dec 24, 2024 | 0.13 | -0.61 |
Crown Holdings | CCK | Dec 24, 2024 | 83.70 | +0.34 |
Crown LNG | CGBS | Dec 24, 2024 | 0.28 | +1.33 |
Cryo-Cell International | CCEL | Dec 24, 2024 | 7.75 | +0.26 |
CryoPort | CYRX | Dec 24, 2024 | 7.87 | +2.34 |
CS Disco | LAW | Dec 24, 2024 | 5.08 | -2.31 |
CSG Systems International | CSGS | Dec 24, 2024 | 51.67 | +1.21 |
CSP | CSPI | Dec 24, 2024 | 15.85 | +3.39 |
CSW Industrials | CSWI | Dec 24, 2024 | 360.30 | +0.82 |
CSX | CSX | Dec 24, 2024 | 32.57 | +1.09 |
CTO Realty Growth | CTO | Dec 24, 2024 | 19.49 | +0.93 |
CTO Realty Growth A Pref | CTO-A | Dec 24, 2024 | 22.00 | -1.26 |
CTS | CTS | Dec 24, 2024 | 53.42 | +0.98 |
CubeSmart | CUBE | Dec 24, 2024 | 43.21 | +0.96 |
Cue Biopharma | CUE | Dec 24, 2024 | 1.01 | -2.88 |
Cullen Frost Bankers B Pref | CFR-B | Dec 24, 2024 | 17.72 | -0.20 |
Cullen/Frost Bankers | CFR | Dec 24, 2024 | 135.96 | +1.24 |
Cullinan Therapeutics | CGEM | Dec 24, 2024 | 12.27 | +3.37 |
Cullman Bancorp | CULL | Dec 24, 2024 | 9.71 | 0.00 |
Culp | CULP | Dec 24, 2024 | 5.78 | +4.90 |
Cumberland Pharmaceuticals | CPIX | Dec 24, 2024 | 2.51 | +11.56 |
Cummins | CMI | Dec 24, 2024 | 353.85 | +0.77 |
Cumulus Media A | CMLS | Dec 24, 2024 | 0.76 | +3.53 |
Curbline Properties | CURB | Dec 24, 2024 | 23.73 | 0.00 |
Curevac N.V. | CVAC | Dec 24, 2024 | 2.99 | +1.01 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.